- Home
- BKE vs ZLAB Comparison
BKE vs ZLAB Comparison
Compare BKE & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKE | ZLAB |
|---|---|---|
| Founded | 1948 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 1996 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BKE | ZLAB |
|---|---|---|
| Price | $48.88 | $18.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $53.00 | $49.60 |
| AVG Volume (30 Days) | 303.8K | ★ 634.6K |
| Earning Date | 05-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.96% | N/A |
| EPS Growth | 6.43 | ★ 38.46 |
| EPS | ★ 4.14 | N/A |
| Revenue | ★ $1,297,835,000.00 | $460,156,000.00 |
| Revenue This Year | $5.10 | $9.75 |
| Revenue Next Year | $4.99 | $26.03 |
| P/E Ratio | $11.84 | ★ N/A |
| Revenue Growth | 6.58 | ★ 15.33 |
| 52 Week Low | $42.09 | $15.96 |
| 52 Week High | $61.69 | $44.34 |
Technical Indicators
Market Signals| Indicator | BKE | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 39.55 |
| Support Level | $48.68 | $18.29 |
| Resistance Level | $56.21 | $19.64 |
| Average True Range (ATR) | 1.51 | 1.01 |
| MACD | -0.23 | -0.21 |
| Stochastic Oscillator | 24.46 | 11.39 |
Price Performance
Historical ComparisonAbout BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.